Criteria for the glucagon provocative test in the diagnosis of gastrinoma

Surgery Today

Volumn 43, Issue 11, 2013, Pages 1281-1285

  Shibata, Chikashi ^a   Kakyo, Masayuki ^a   Kinouchi, Makoto ^a   Tanaka, Naoki ^a   Miura, Koh ^a   Naitoh, Takeshi ^a   Ogawa, Hitoshi ^a   Motoi, Fuyuhiko ^a   Egawa, Shinichi ^a   Ueno, Tatsuya ^b   Naito, Hiroo ^b   Unno, Michiaki ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b South Miyagi Medical Center   (Japan)

Author keywords

Gastrinoma; Glucagon; Pancreaticoduodenectomy

Indexed keywords

GASTRIN; GLUCAGON; GLUCAGON G NOVO; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GASTRIN BLOOD LEVEL; GASTRINOMA; GLUCAGON PROVOCATIVE TEST; HISTOLOGY; HUMAN; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PREOPERATIVE PERIOD; PROVOCATION TEST;

AGED; FEMALE; GASTRINOMA; GASTRINS; GLUCAGON; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PANCREATIC FUNCTION TESTS; PANCREATIC NEOPLASMS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84886090495     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-012-0334-2     Document Type: Article

References (17)

1. Murugesan SVM, Varro A, Pritchard DM. Strategies to determine whether hypergastrinemia is due to Zollinger-Ellison syndrome rather than a more common benign cause. Aliment Pharmacol Ther. 2009;29:1055-68.
2. Isenberg JI, Walsh JH, Passaro E Jr, Moore EW, Grossman MI. Unusual effect of secretin on plasma gastrin and gastric acid secretion in a patient with suspected Zollinger-Ellison syndrome. Gastroenterology. 1972;62:626-31.
3. Deveney CW, Deveney KS, Jaffe BM, Jones RS, Way LW. Use of calcium and secretin in the diagnosis of gastrinoma (Zollinger-Ellison syndrome). Ann Intern Med. 1977;87:680-6.
4. Lamers CB. Clinical usefulness of the secretin provocation test. J Clin Gastroenterol. 1981;3:255-9.
5. Turner JJO, Wren AM, Jackson JE, Thakker RV, Meeran K. Localization of gastrinomas by selective intra-arterial calcium injection. Clin Endocrinol. 2002;57:821-5.
6. Wada M, Komoto I, Doi R, Imamura M. Intravenous calcium injection test is a novel complementary procedure in differential diagnosis for gastrinoma. World J Surg. 2002;26:1291-6.
7. Shibata C, Funayama Y, Fukushima K, Ueno T, Kohyama A, Satoh K, et al. The glucagon provocative test for the diagnosis and treatment of Zollinger-Ellison syndrome. J Gastrointest Surg. 2008;12:344-9.
8. Korman MG, Soveny C, Hansky J. Effect of glucagon on plasma gastrin. II: studies in pernicious anemia and the Zollinger-Ellison syndrome. Gut. 1973;14:459-61.
9. Frucht H, Howard JM, Slaff JI, Wank SA, McCarthy DM, Maton PN, et al. Secretin and calcium provocative tests in Zollinger-Ellison syndrome. Ann Intern Med. 1989;111:713-22.
10. Berna MJ, Hoffmann KM, Long SH, Serano J, Gibril F, Jensen RT. Plasma gastrin in Zollinger-Ellison syndrome: II. Prospective study on gastrin provocative testing in 293 patients from the National Institute of Health and comparison with 537 cases from the literature. Evaluation of diagnostic criteria, proposal of new criteria, and correlation with clinical and tumoral features. Medicine (Baltimore). 2006;85:331-64.
11. Thompson JC, Reeder DD, Villar HV, Fender HR. Natural history and experience with diagnosis and treatment of the Zollinger-Ellison syndrome. Surg Gynecol Obstet. 1975;140:721-39.
12. Imamura M, Komoto I, Ota S. Changing treatment strategy for gastrinoma in patients with Zollinger-Ellison syndrome. World J Surg. 2006;30:1-11.
13. Roy PK, Venzon DJ, Shojamanesh H, Abou-Saif A, Peghini P, Doppman JL, et al. Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore). 2000;79:379-411.
14. Shibata C, Funayama Y, Fukushima K, Takahashi K, Ueno T, Nagao M, et al. Role of selective arterial secretin injection test in treatment of gastrinoma. Hepatogastroenterology. 2006;52:960-3.
15. Hansky J, Soveny C, Korman MG. The effect of glucagon on plasma gastrin. I: studies in normal subjects. Gut. 1973;14:457-61.
16. Long SH, Berna MJ, Thill M, Pace A, Pradhan TK, Hoffmann KM, et al. Secretin-receptor and secretin-receptor-variant expression in gastrinomas: correlation with clinical and tumoral features and secretin and calcium provocative test results. J Clin Endocrinol Metab. 2007;92:4394-402.
17. Tang C, Biemond I, Lamers CB. Expression of peptide receptors in human endocrine tumours of the pancreas. Gut. 1997;40:267-71.